Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discoidin domain receptors orchestrate cancer progression: A focus on cancer therapies
Yuan Gao, Jiuli Zhou, Jin Li
Cancer Science (2020) Vol. 112, Iss. 3, pp. 962-969
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Recent progress in targeted therapy for non-small cell lung cancer
Yanxia Xiao, Pu Liu, Jie Wei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 44
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
Ahmed Elkamhawy, Qili Lu, Hossam Nada, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6535-6535
Open Access | Times Cited: 73
Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment
Kena Song, Zhangqing Yu, Xiangyang Zu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10509-10509
Open Access | Times Cited: 49
A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer
Junquan Liu, Huai-Chin Chiang, Wei Xiong, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006720-e006720
Open Access | Times Cited: 28
Recent Advances on Collagen Biomaterial: From Extraction, Cross-Linking to Tissue Regeneration
Lian Zhu, Ze-Long Yu, Sheng Li, et al.
Polymer Reviews (2024) Vol. 64, Iss. 4, pp. 1031-1059
Closed Access | Times Cited: 8
Recombinant CD80 fusion protein combined with discoidin domain receptor 1 inhibitor for cancer treatment
Songna Wang, Pinliang Hu, Xuyao Zhang, et al.
Applied Microbiology and Biotechnology (2025) Vol. 109, Iss. 1
Open Access | Times Cited: 1
Pharmacological targeting of ECM homeostasis, fibroblast activation, and invasion for the treatment of pulmonary fibrosis
Ioannis Tomos, Paraskevi Kanellopoulou, Dimitris Nastos, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access | Times Cited: 1
Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
Jingtao Chen, Chao Niu, Ning Yang, et al.
Pharmacological Research (2023) Vol. 189, pp. 106674-106674
Open Access | Times Cited: 18
Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer
Hanyu Zhang, Cheng Ding, Yatong Li, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 3634-3646
Open Access | Times Cited: 35
Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer
Li Chen, Xiangyi Kong, Yi Fang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 33
DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor‐infiltrating T cells through IL‐18
Xiaofan Duan, Xiaoxiao Xu, Yumei Zhang, et al.
Cancer Science (2022) Vol. 113, Iss. 11, pp. 3672-3685
Open Access | Times Cited: 26
Research progress of DDR1 inhibitors in the treatment of multiple human diseases
Mengying Liu, Jifa Zhang, Xiaoxue Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116291-116291
Closed Access | Times Cited: 4
Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1
Coralie Reger de Moura, Baptiste Louveau, Fanélie Jouenne, et al.
Oncogene (2024) Vol. 43, Iss. 21, pp. 1620-1630
Closed Access | Times Cited: 4
Discovery of a prominent dual-target DDR1/EGFR inhibitor aimed DDR1/EGFR-positive NSCLC
Xuebao Wang, Ying Lu, Siyu Chen, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107500-107500
Closed Access | Times Cited: 4
Explanatory review on DDR inhibitors: their biological activity, synthetic route, and structure–activity relationship
Sindhuja Sengupta, Lalmohan Maji, Pronoy Kanti Das, et al.
Molecular Diversity (2025)
Closed Access
Chemical Synthesis of Novel DDR1 Inhibitors and Their Activity Against Gefitinib-Resistant Non-Small Cell Lung Cancer
Xuemei Xu, Siyu Chen, Doudou Sun, et al.
Russian Journal of Bioorganic Chemistry (2025) Vol. 51, Iss. 1, pp. 285-297
Closed Access
Discovery of Novel DDR1 Inhibitors through a Hybrid Virtual Screening Pipeline, Biological Evaluation and Molecular Dynamics Simulations
Xinglong Chi, Roufen Chen, Xiaoxiao Yang, et al.
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 4, pp. 602-610
Open Access
Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer
Meiling Zhang, Bin Zhang
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
ECM, integrins, and DDRs: A nexus of cancer progression, therapy, and future directions
M A Azim, Julie S. Di Martino
Matrix Biology (2025) Vol. 138, pp. 27-43
Closed Access
Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity relationship
Ganesh Prasad Shenoy, Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, et al.
Bioorganic Chemistry (2022) Vol. 130, pp. 106215-106215
Closed Access | Times Cited: 18
COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction
Zhihui Wen, Jingbo Sun, Junjie Luo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
New target DDR1: A “double-edged sword” in solid tumors
Yonggang Tian, Feihu Bai, Dekui Zhang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188829-188829
Closed Access | Times Cited: 16
Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer
Sida Hao, Zitong Yang, Gang Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
CAM-DR: Mechanisms, Roles and Clinical Application in Tumors
Yuejiao Huang, Yuchan Wang, Jie Tang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 20
Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact
Kaouther Ben Arfi, Christophe Schneider, Amar Bennasroune, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 928-928
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top